Dear Editor,

Lifelong premature ejaculation (LPE) is a type of sexual dysfunction in males and has three characteristics: (1) an intravaginal ejaculatory latency time (IELT) of ≤1 min; (2) insufficient control over delaying ejaculation; and (3) negative personal consequences, such as distress, frustration, and/or the avoidance of sexual intimacy.[@ref1] Its etiologies involve the 5-hydroxytryptamine (5-HT) system. The use of 5-HT transporter (5-HTT) blockers (e.g., selective serotonin reuptake inhibitors, SSRIs) was found to prevent the reuptake of 5-HT from the synaptic cleft into the presynaptic serotonergic neurons, which leads to increased extracellular 5-HT levels, thereby delaying ejaculation.[@ref2] The 5-HTT gene (*SLC6A4*) on human chromosome 17 thus became a candidate target gene for treating LPE and had been isolated and characterized. All of the gene\'s exons and the adjacent intronic sequences, as well as a tandem repeat DNA polymorphism within the *SLC6A4* gene, have been sequenced.[@ref3] Polymorphisms in the serotonin transporter gene-linked polymorphic region (*5-HTTLPR*) and in the second intron (*STin2*) have been studied in LPE, but the findings were inconsistent.[@ref4][@ref5] Other polymorphisms (e.g., single-nucleotide polymorphisms) in this gene have been widely studied in patients with psychosis[@ref6][@ref7] but not in patients with LPE.

In the present study, our team explored the association with LPE of single-nucleotide polymorphisms (SNPs) in the 3' untranslated region (UTR) and 5' UTR, and of single-nucleotide variants (SNVs) in all exons of *SLC6A4*. We enrolled 101 men diagnosed with LPE from our outpatient clinics and 99 age-matched healthy controls from the health examination center. All subjects were genotyped for polymorphisms in the 3' UTR, 5' UTR and all exons of *SLC6A4*. For *SLC6A4*, both the LPE group and the control group showed no significant deviation (*P* \> 0.05) from the Hardy-Weinberg equilibrium (HWE). The SNPs including rs25533, rs6354, rs7224199, rs8066731, and rs1042173 ([www.ncbi.nlm.nih.gov/snp/](www.ncbi.nlm.nih.gov/snp/)) were identified and analyzed in this study, and the minor allele frequency of these SNPs in the sample population was 11.8%, 12.6%, 18.2%, 18.3%, and 18.1%, respectively. We did not find significant differences between the LPE patients and the controls (*P* \> 0.05). Across all exons, several SNVs were located and analyzed (**[Table 1](#T1){ref-type="table"}**). Still, no significant differences were found between the LPE group and the control group (*P* \> 0.05). We also assessed linkage disequilibrium (LD) between polymorphisms and found that the SNPs rs8066731, rs7224199, and rs1042173 in the 3' UTR were located in the observed LD block. Haplotype association analyses for the block, with respect to LPE, were performed with HAPLOVIEW (version 4.1, Broad Institute of Harvard and MIT, Cambridge, MA, USA). The results showed no significant haplotype association with LPE (*P* \> 0.05).
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LPE is a complex sexual dysfunction involving the 5-HT system. Multiple, well-controlled evidence-based studies have demonstrated the efficacy and safety of SSRIs for delaying ejaculation, thus confirming their role as first-line agents for the treatment of LPE and acquired premature ejaculation (APE).[@ref8] Medications for SSRI-associated sexual side effects inhibit 5-HTT and increase the synaptic latency period of 5-HT molecules, thereby facilitating the modulation of postsynaptic serotonin receptors.[@ref2] To explore the moderate effect of genes on LPE, studies have attempted to uncover whether there is an association between LPE and the *SLC6A4* gene. Zuccarello *et al*.[@ref4] reported that no significant differences were found in the frequency of *5-HTTLPR* gene polymorphisms in LPE patients and controls. In contrast, a significant association between LPE and the *5-HTTLPR* short (S) allele and the SS genotype has been reported.[@ref5] However, this study was criticized because the sample population deviated from HWE.[@ref9] In the current study, we explored whether polymorphisms in the 3' UTR, 5' UTR and the exons of *SLC6A4* were associated with LPE. The results of our study showed that polymorphisms in the UTRs and the exons were not significantly associated with LPE in the Han population (*P* \> 0.05). However, PE is a complex sexual dysfunction, and its moderate genetic effect cannot be explained by a single gene. For example, in the Han population, Luo *et al*.[@ref10] explored whether 5-HT~2C~ receptor gene polymorphism in LPE influenced IELT in men with LPE.

To the best of our knowledge, this is the first study to test the association between LPE and SNPs or SNVs in the *SLC6A4* gene. In the sample population, no significant association was found between LPE and polymorphisms in the *SLC6A4* gene. Further investigation in this field is needed.
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